Cited by 6,763Computational Drug Discovery MethodsProtein Structure and DynamicsProtein Interaction Studies and Fluorescence Analysis

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen

Jones, Gareth, Willett, Peter, Glen, Robert C, Leach, Andrew R, Taylor, Robin·1997·Journal of Molecular Biology

DOI 10.1006/jmbi.1996.0897

Open this paper in CoChat — free account

Abstract

Prediction of small molecule binding modes to macromolecules of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem). We report the development and validation of the program GOLD (Genetic Optimisation for Ligand Docking). GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein, and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding. Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm. The advanced algorithm has been tested on a dataset of 100 complexes extracted from the Brookhaven Protein DataBank. When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the experimental binding mode.

Integrity signals

Registry

Crossref · 10.1006/jmbi.1996.0897

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Genetic algorithms in search, optimization, and machine learning
(1989) · Choice Reviews Online · doi:10.5860/choice.27-0936 · Cited by 49,178
Adaptation in Natural and Artificial Systems
Holland, J. H. (1992) · The MIT Press eBooks · doi:10.7551/mitpress/1090.001.0001 · Cited by 47,340
Molecular Theory of Gases and Liquids
Hirschfelder, J. O., Curtiss, C. F., & Bird, R. B. (1955) · Physics Today · doi:10.1063/1.3061949 · Cited by 11,445
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,574
Molecular theory of gases and liquids
Scott, R. L. (1955) · Journal of Chemical Education · doi:10.1021/ed032p232.2 · Cited by 3,958
Semianalytical treatment of solvation for molecular mechanics and dynamics
Still, W. C., Tempczyk, A., Hawley, R. C., & Hendrickson, T. F. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00172a038 · Cited by 3,653
A Fast Flexible Docking Method using an Incremental Construction Algorithm
Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,836
Validation of the general purpose tripos 5.2 force field
Clark, M., CRAMER, R. D. I., & Opdenbosch, N. V. (1989) · Journal of Computational Chemistry · doi:10.1002/jcc.540100804 · Cited by 2,803
Analytical molecular surface calculation
Connolly, M. L. (1983) · Journal of Applied Crystallography · doi:10.1107/s0021889883010985 · Cited by 2,521
A geometric approach to macromolecule-ligand interactions
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90153-x · Cited by 2,287

Flagged first, then by citations

Show all 87 references

Research works printed but not linked: 2

Dreyer, 1992, Hydroxyethylene isostere inhibitors of human immunodeficiency virus-I protease, Biochemistry, 31
Padlan, 1985, On the specificity of antibody 3-antigen interactions, Ann. Immunol. (Paris), C136, 271

Sorted by citations

Items 501–600 of 1,019

AutoGrow: A Novel Algorithm for Protein Inhibitor Design
Durrant, J. D., Amaro, R. E., & McCammon, J. A. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00761.x · Cited by 117
Automated Protein Structure Homology Modeling: A Progress Report
Kopp, J., & Schwede, T. F. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.4.405 · Cited by 113
Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1
Bissinger, E.-M., Heinke, R., Spannhoff, A., Eberlin, A., Metzger, E., Cura, V., Hassenboehler, P., Cavarelli, J., Schüle, R., Bedford, M. T., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.032 · Cited by 112
A pharmacophore‐based evolutionary approach for screening selective estrogen receptor modulators
Yang, J., & Shen, T.-W. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20387 · Cited by 114
Molecular Docking: From Lock and Key to Combination Lock
Tripathi, A., & Bankaitis, V. A. (2018) · Journal of Molecular Medicine and Clinical Applications · doi:10.16966/2575-0305.106 · Cited by 130
Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors
Xu, R., Zhao, Y., Liu, L., Bai, L., Yang, C., Zhou, B. N., Meagher, J. L., Chinnaswamy, K., Stuckey, J. A., & Wang, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00613 · Cited by 112
Evolution of the bile salt nuclear receptor FXR in vertebrates*
Reschly, E. J., Ai, N., Ekins, S., Welsh, W. J., Hagey, L. R., Hofmann, A. F., & Krasowski, M. D. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800138-jlr200 · Cited by 113
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors
Patil, S. A., Kamath, S., Sanchez, T. W., Neamati, N., Schinazi, R. F., & Buolamwini, J. K. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.11.026 · Cited by 112
Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6
Paine, M. J. I., McLaughlin, L. A., Flanagan, J. U., Kemp, C. A., Sutcliffe, M. J., Roberts, G. C. K., & Wolf, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209519200 · Cited by 112
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor
Zhang, P., Huang, W., Wang, L., Bao, L., Jia, Z. J., Bauer, S. M., Goldman, E. A., Probst, G. D., Song, Y., Su, T., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.111 · Cited by 112
Binding Mode Prediction of Cytochrome P450 and Thymidine Kinase Protein−Ligand Complexes by Consideration of Water and Rescoring in Automated Docking
de Graaf, C., Pospíšil, P., Pos, W., Folkers, G., & Vermeulen, N. P. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049650u · Cited by 111
Discovery of Small Molecule Integrin αvβ3 Antagonists as Novel Anticancer Agents
Dayam, R., Aiello, F., Deng, J. N., Wu, Y., Garofalo, A., Chen, X. S., & Neamati, N. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051296s · Cited by 111
Identification of Critical Residues in Novel Drug Metabolizing Mutants of Cytochrome P450 BM3 Using Random Mutagenesis
van Vugt‐Lussenburg, B. M. A., Stjernschantz, E., Lastdrager, J., Oostenbrink, C., Vermeulen, N. P. E., & Commandeur, J. N. M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0609061 · Cited by 111
Curcumin Recognizes a Unique Binding Site of Tubulin
Chakraborti, S., Das, L., Kapoor, N., Das, A. K., Dwivedi, V., Poddar, A., Chakraborti, G., Janik, M. E., Basu, G., Panda, D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2004046 · Cited by 111
Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
Klaeger, S., Gohlke, B.-O., Perrin, J., Gupta, V., Heinzlmeir, S., Helm, D., Qiao, H., Bergamini, G., Handa, H., Savitski, M. M., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01063 · Cited by 111
Discovery of Novel Nitrobenzothiazole Inhibitors for Mycobacterium tuberculosis ATP Phosphoribosyl Transferase (HisG) through Virtual Screening
Cho, Y., Ioerger, T. R., & Sacchettini, J. C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800328v · Cited by 110
Structure-based screening of low-affinity compounds
Carr, R. A. E., & Jhoti, H. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02245-6 · Cited by 112
10-Iodo-11 H -indolo[3,2- c ]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
Falke, H., Chaikuad, A., Becker, A., Loaëc, N., Lozach, O., Jhaisha, S. A., Becker, W. B., Jones, P. G., Preu, L., Baumann, K., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501994d · Cited by 115
Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR
Ekins, S., Kortagere, S., Iyer, M., Reschly, E. J., Lill, M. A., Redinbo, M. R., & Krasowski, M. D. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000594 · Cited by 109
Learning from the ligand: using ligand-based features to improve binding affinity prediction
Boyles, F., Deane, C. M., & Morris, G. M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz665 · Cited by 111
Computational design of enzymes for biotechnological applications
Planas-Iglesias, J., Marques, S. M., Pinto, G., Musil, M., Štourač, J., Damborský, J., & Bednář, D. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107696 · Cited by 107
Recovering the true targets of specific ligands by virtual screening of the protein data bank
Paul, N., Kellenberger, E., Bret, G., Müller, P., & Rognan, D. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10625 · Cited by 109
Molecular Interaction Studies of Trimethoxy Flavone with Human Serum Albumin
Gokara, M., Sudhamalla, B., Damu, A. G., & Subramanyam, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008834 · Cited by 108
Prediction of cytochrome P450 mediated metabolism
Olsen, L., Oostenbrink, C., & Jørgensen, F. S. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.020 · Cited by 108
Decoys Selection in Benchmarking Datasets: Overview and Perspectives
Réau, M. F., Langenfeld, F., Zagury, J., Lagarde, N., & Montès, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00011 · Cited by 118
Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study
Creanza, T. M., Delre, P., Ancona, N., Lentini, G., Saviano, M., & Mangiatordi, G. F. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00744 · Cited by 114
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas
Przystal, J. M., Cosentino, C., Yadavilli, S., Zhang, J., Laternser, S., Bonner, E. R., Prasad, R., Dawood, A., Lobeto, N., Chong, W. C., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac041 · Cited by 108
Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches
Catto, M., Nicolotti, O., Leonetti, F., Carotti, A., Favia, A. D., Soto‐Otero, R., Méndez‐Álvarez, E., & Carotti, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060183l · Cited by 108
QM/MM Studies on the β-Galactosidase Catalytic Mechanism: Hydrolysis and Transglycosylation Reactions
Brás, N. F., Fernandes, P. A., & Ramos, M. J. (2010) · Journal of Chemical Theory and Computation · doi:10.1021/ct900530f · Cited by 108
2-Substituted Estradiol Bis-sulfamates, Multitargeted Antitumor Agents: Synthesis, In Vitro SAR, Protein Crystallography, and In Vivo Activity
Leese, M. P., Leblond, B., Smith, A., Newman, S. P., Fiore, A. D., Simone, G. D., Supuran, C. T., Purohit, A., Reed, M. J., & Potter, B. V. L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060705x · Cited by 108
From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling
Sanders, M. P. A., McGuire, R., Roumen, L., de Esch, I. J. P., de Vlieg, J., Klomp, J. P. G., & de Graaf, C. (2011) · MedChemComm · doi:10.1039/c1md00210d · Cited by 114
Docking Ligands into Flexible and Solvated Macromolecules. 3. Impact of Input Ligand Conformation, Protein Flexibility, and Water Molecules on the Accuracy of Docking Programs
Corbeil, C. R., & Moitessier, N. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8004176 · Cited by 111
The P450 CYP 6Z1 confers carbamate/pyrethroid cross‐resistance in a major African malaria vector beside a novel carbamate‐insensitive N485I acetylcholinesterase‐1 mutation
Ibrahim, S. S., Ndula, M., Riveron, J. M., Irving, H., & Wondji, C. S. (2016) · Molecular Ecology · doi:10.1111/mec.13673 · Cited by 106
Integrated Computational Approaches and Tools for Allosteric Drug Discovery
Amamuddy, O. S., Veldman, W., Manyumwa, C. V., Khairallah, A., Agajanian, S., Odeyemi, O., Verkhivker, G. M., & Bishop, Ö. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030847 · Cited by 107
A motion planning approach to flexible ligand binding.
Singh, A. P., Latombe, J.-C., & Brutlag, D. L. (1999) · PubMed · Cited by 107
Current topics in computer‐aided drug design
Taft, C. A., da Silva, V. B., & da Silva, C. H. T. D. P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21293 · Cited by 107
Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor
Gellibert, F. J., de Gouville, A., Woolven, J. M., Mathews, N., Nguyen, V.-L., Ruault, C., Patikis, A. N., Grygielko, E. T., Laping, N. J., & Huet, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509905 · Cited by 107
Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of α-glucosidase inhibitors
Bharatham, K., Bharatham, N., Park, K. H., & Lee, K. W. (2007) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2007.11.002 · Cited by 107
17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer
Day, J. M., Foster, P., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23350 · Cited by 107
An In Silico Approach to Discovering Novel Inhibitors of Human Sirtuin Type 2
Tervo, A. J., Kyrylenko, S., Niskanen, P., Salminen, A., Leppänen, J., Nyrönen, T., Järvinen, T., & Poso, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049933m · Cited by 107
Design, synthesis and neuroprotective evaluation of novel tacrine–benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease
Keri, R. S., Quintanova, C., Marques, S. M., Esteves, A. R., Cardoso, S. M., & Santos, M. A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.028 · Cited by 107
Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1′ Pocket in the Design of Selective, Small Molecule Inhibitors
Fabre, B., Ramos, A., & de Pascual‐Teresa, B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500505f · Cited by 106
Memetic Algorithms
Moscato, P., Cotta, C., & Mendes, A. S. (2004) · Studies in fuzziness and soft computing · doi:10.1007/978-3-540-39930-8_3 · Cited by 106
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
Li, Y., Zhang, L., Wang, Y., Zou, J., Yang, R., Luo, X., Wu, C., Yang, W. M., Tian, C., Xu, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34692-w · Cited by 113
Drug block of the hERG potassium channel: Insight from modeling
Stansfeld, P. J., Gedeck, P., Gosling, M., Cox, B. J., Mitcheson, J. S., & Sutcliffe, M. J. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21400 · Cited by 106
Synthesis and Biological Evaluation of Novel Analogues of the Pan Class I Phosphatidylinositol 3-Kinase (PI3K) Inhibitor 2-(Difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1 H -benzimidazole (ZSTK474)
Rewcastle, G. W., Gamage, S. A., Flanagan, J. U., Frédérick, R., Denny, W. A., Baguley, B. C., Kestell, P., Singh, R., Kendall, J. D., Marshall, E. S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200688y · Cited by 107
Estimation of subpixel land surface temperature using an endmember index based technique: A case examination on ASTER and MODIS temperature products over a heterogeneous area
Yang, G., Pu, R., Zhao, C., Huang, W., & Wang, J. (2011) · Remote Sensing of Environment · doi:10.1016/j.rse.2011.01.004 · Cited by 106
A Second Receptor Binding Site on Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Contributes to Activation of the FusionMechanism
Porotto, M., Fornabaio, M., Kellogg, G. E., & Moscona, A. (2007) · Journal of Virology · doi:10.1128/jvi.02617-06 · Cited by 106
EUDOC: a computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases
Pang, Y., Perola, E., Xu, K., & Prendergast, F. G. (2001) · Journal of Computational Chemistry · doi:10.1002/jcc.1129 · Cited by 106
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties
Joshi, S. D., Dixit, S. R., Kirankumar, M. N., Aminabhavi, T. M., Raju, K. V. S. N., Narayan, R., Lherbet, C., & Yang, K. S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.047 · Cited by 105
Structural Studies of Cinnamoyl-CoA Reductase and Cinnamyl-Alcohol Dehydrogenase, Key Enzymes of Monolignol Biosynthesis
Pan, H., Zhou, R., Louie, G. V., Mühlemann, J. K., Bomati, E. K., Bowman, M. E., Dudareva, N., Dixon, R. A., Noel, J. P., & Wang, X. (2014) · The Plant Cell · doi:10.1105/tpc.114.127399 · Cited by 105
Structure-Based Virtual Screening
Li, Q., & Shah, S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6783-4_5 · Cited by 107
Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis
Marahatha, R., Basnet, S., Bhattarai, B. R., Budhathoki, P., Aryal, B., Adhikari, B., Lamichhane, G., Poudel, D. K., & Parajuli, N. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03162-5 · Cited by 106
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies
Bassani, D., & Moro, S. (2023) · Molecules · doi:10.3390/molecules28093906 · Cited by 116
2-Thiazolylimino/Heteroarylimino-5-arylidene-4-thiazolidinones as New Agents with SHP-2 Inhibitory Action
Geronikaki, A. A., Eleftheriou, P. T., Vicini, P., Alam, I., Dixit, A., & Saxena, A. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8004306 · Cited by 108
Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications
Sankaran, S., Panigrahi, S., & Mallik, S. (2010) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2010.08.003 · Cited by 105
Swarm Intelligence Algorithms in Bioinformatics
Das, S., Abraham, A., & Konar, A. (2008) · Studies in computational intelligence · doi:10.1007/978-3-540-76803-6_4 · Cited by 105
LEADS-PEP: A Benchmark Data Set for Assessment of Peptide Docking Performance
Hauser, A. S., & Windshügel, B. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00234 · Cited by 105
MathDL: mathematical deep learning for D3R Grand Challenge 4
Nguyen, D. D., Gao, K., Wang, M., & Wei, G. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00237-5 · Cited by 105
The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors
Otava, T., Šála, M., Li, F., Fanfrlík, J., Devkota, K., Perveen, S., Chau, I., Pakarian, P., Hobza, P., Vedadi, M., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00131 · Cited by 104
Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Fletcher, S., Turkson, J., & Gunning, P. T. (2008) · ChemMedChem · doi:10.1002/cmdc.200800123 · Cited by 105
A novel arginine methyltransferase inhibitor with cellular activity
Spannhoff, A., Machmur, R., Heinke, R., Trojer, P., Bauer, I., Brosch, G., Schüle, R., Hanefeld, W., Sippl, W., & Jung, M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.088 · Cited by 104
Molecular modeling of the second extracellular loop of G‐protein coupled receptors and its implication on structure‐based virtual screening
de Graaf, C., Foata, N., Engkvist, O., & Rognan, D. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21724 · Cited by 104
Signal transducer and activator of transcription 3 inhibitors: a patent review
Page, B. D. G., Ball, D. P., & Gunning, P. T. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.539205 · Cited by 103
CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma
Carlson, H. A., Smith, R. D., Damm‐Ganamet, K. L., Stuckey, J. A., Ahmed, A., Convery, M. A., Somers, D. O., Kranz, M., Elkins, P. A., Cui, G., et al. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00523 · Cited by 105
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode
Sawatzky, E., Wehle, S., Kling, B., Wendrich, J., Bringmann, G., Sotriffer, C., Heilmann, J., & Decker, M. W. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01674 · Cited by 102
Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction
Karataş, H., Li, Y., Liu, L., Ji, J., Lee, S. H. F., Chen, Y., Yang, J., Huang, L., Bernard, D., Xu, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01796 · Cited by 103
EDock: blind protein–ligand docking by replica-exchange monte carlo simulation
Zhang, W., Bell, E. W., Yin, M., & Zhang, Y. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00440-9 · Cited by 103
Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
Zrieq, R. M., Ahmad, I., Snoussi, M., Noumi, E., Iriti, M., Algahtani, F. D., Patel, H., Saeed, M., Tasleem, M., Sulaiman, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910693 · Cited by 103
Differential Inhibition of Adenylyl Cyclase Isoforms and Soluble Guanylyl Cyclase by Purine and Pyrimidine Nucleotides
Gille, A., Lushington, G. H., Mou, T., Doughty, M. B., Johnson, R. A., & Seifert, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312560200 · Cited by 104
Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids
Siemoneit, U., Hofmann, B., Kather, N., Lamkemeyer, T., Madlung, J., Franke, L., Schneider, G., Jauch, J., Poeckel, D., & Werz, O. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.010 · Cited by 103
3,5-Disubstituted-thiazolidine-2,4-dione analogs as anticancer agents: Design, synthesis and biological characterization
Liu, K., Rao, W., Parikh, H. I., Li, Q., Guo, T. L., Grant, S., Kellogg, G. E., & Zhang, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.031 · Cited by 103
N-Benzylisatin Sulfonamide Analogues as Potent Caspase-3 Inhibitors: Synthesis, in Vitro Activity, and Molecular Modeling Studies
Chu, W., Zhang, J., Zeng, C., Rothfuss, J. M., Tu, Z., Chu, Y., Reichert, D. E. C., Welch, M. J., & Mach, R. H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0506625 · Cited by 103
Evaluation of library ranking efficacy in virtual screening
Kontoyianni, M., Sokol, G. S., & McClellan, L. M. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20141 · Cited by 103
Fluorescence and Docking Studies of the Interaction between Human Serum Albumin and Pheophytin
Chaves, O. A., de Amorim, A. C., Castro, L., Sant’Anna, C. M. R., de Oliveira, M. C. C., Cesarin-Sobrinho, D., Netto‐Ferreira, J. C., & Ferreira, A. B. B. (2015) · Molecules · doi:10.3390/molecules201019526 · Cited by 102
Computer-Aided Drug Design: Lead Discovery and Optimization
Xiang, M., Cao, Y., Fan, W., Chen, L., & Mo, Y. (2012) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620712799361825 · Cited by 102
Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors
Weigel, L. F., Nitsche, C., Graf, D., Bartenschlager, R. F. W., & Klein, C. D. P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00612 · Cited by 102
Binding studies of lophirone B with bovine serum albumin (BSA): Combination of spectroscopic and molecular docking techniques
Chaves, O. A., da Silva, V. A., Sant’Anna, C. M. R., Ferreira, A. B. B., Ribeiro, T. A. N., de Carvalho, M. G., Cesarin-Sobrinho, D., & Netto‐Ferreira, J. C. (2016) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2016.09.036 · Cited by 102
Binding mode analysis, dynamic simulation and binding free energy calculations of the MurF ligase from Acinetobacter baumannii
Ahmad, S., Raza, S., Uddin, R., & Azam, S. S. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.07.024 · Cited by 104
Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications
Bian, Y., & Xie, X.-Q. S. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0216-7 · Cited by 103
Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets
He, J., Chen, L.-X., & Li, H. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.02.033 · Cited by 102
Homology modeling of opioid receptor-ligand complexes using experimental constraints
Pogozheva, I. D., Przydzial, M. J., & Mosberg, H. I. (2005) · The AAPS Journal · doi:10.1208/aapsj070243 · Cited by 102
siRNA screen identifies QPCT as a druggable target for Huntington's disease
Jiménez-Sánchez, M., Lam, W., Hannus, M., Sönnichsen, B., Imarisio, S., Fleming, A., Tarditi, A., Menzies, F. M., Dami, T. E., Xu, C. K., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1790 · Cited by 102
VoteDock: Consensus docking method for prediction of protein–ligand interactions
Plewczyński, D., Łaźniewski, M., von Grotthuss, M., Rychlewski, L., & Ginalski, K. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21642 · Cited by 105
Prediction of binding modes for ligands in the cytochromes P450 and other heme‐containing proteins
Kirton, S. B., Murray, C. W., Verdonk, M. L., & Taylor, R. D. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20389 · Cited by 102
Bioinformatics with soft computing
Mitra, S., & Hayashi, Y. (2006) · IEEE Transactions on Systems Man and Cybernetics Part C (Applications and Reviews) · doi:10.1109/tsmcc.2006.879384 · Cited by 103
Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
Nayarisseri, A., Khandelwal, R., Tanwar, P., Madhavi, M., Sharma, D., Thakur, G., Speck‐Planche, A., & Singh, S. K. (2021) · Current Drug Targets · doi:10.2174/1389450122999210104205732 · Cited by 105
Structural insights into the inhibition of glycine reuptake
Shahsavar, A., Stohler, P., Bourenkov, G. P., Zimmermann, I., Siegrist, M., Guba, W., Pinard, E., Sinning, S., Seeger, M. A., Schneider, T. R., et al. (2021) · Nature · doi:10.1038/s41586-021-03274-z · Cited by 105
Peptidic modulators of protein‐protein interactions: Progress and challenges in computational design
Rubinstein, M., & Niv, M. Y. (2009) · Biopolymers · doi:10.1002/bip.21164 · Cited by 101
Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2
Calamini, B., Santarsiero, B. D., Boutin, J. A., & Mesecar, A. D. (2008) · Biochemical Journal · doi:10.1042/bj20071373 · Cited by 101
Synthesis and Structure–Affinity Relationships of Selective High-Affinity 5-HT 4 Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers
Dubost⧫, E., Dumas, N., Fossey, C., Magnelli, R., Butt‐Gueulle, S., Ballandonne, C., Caignard, D. H., Dulin, F., Santos, J. S. O., Millet, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300943r · Cited by 101
GPCR Structure-Based Virtual Screening Approach for CB2 Antagonist Search
Chen, J.-Z., Wang, J., & Xie, X. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci7000814 · Cited by 101
Synthesis, Biological Evaluation, And Molecular Modeling of Chalcone Derivatives As Potent Inhibitors of Mycobacterium tuberculosis Protein Tyrosine Phosphatases (PtpA and PtpB)
Chiaradia, L. D., Martins, P. G. A., Cordeiro, M. N. S., Guido, R. V. C., Ecco, G., Andricopulo, A. D., Yunes, R. A., Vernal, J. I., Nunes, R. J., & Terenzi, H. F. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2012062 · Cited by 101
Pharmacophore‐Based Discovery of Small‐Molecule Inhibitors of Protein–Protein Interactions between HIV‐1 Integrase and Cellular Cofactor LEDGF/p75
Luca, L. D., Barreca, M. L., Ferro, S., Christ, F., Iraci, N., Gitto, R., Monforte, A., Debyser, Z., & Chimirri, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900070 · Cited by 100
Bio-Inspired Algorithms Applied to Molecular Docking Simulations
Heberlé, G., & de Azevedo, W. F. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795029573 · Cited by 103
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated
Géraldy, M. N. E., Morgen, M., Sehr, P. A., Steimbach, R. R., Moi, D., Ridinger, J., Oehme, I., Witt, O., Malz, M., Nogueira, M. S., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01936 · Cited by 96
Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking
Caporuscio, F., Rastelli, G., Imbriano, C., & Río, A. D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000689 · Cited by 101
Ph4Dock: Pharmacophore-Based Protein−Ligand Docking
Goto, J.-I., Kataoka, R., & Hirayama, N. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0493818 · Cited by 104
Protein-Ligand Binding Affinity Predictions by Implicit Solvent Simulations: A Tool for Lead Optimization?
Michel, J., Verdonk, M. L., & Essex, J. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061021s · Cited by 100
Antimalarial 4(1H)-pyridones bind to the Q i site of cytochrome bc 1
Capper, M. J., O’Neill, P. M., Fisher, N. E., Strange, R. W., Moss, D. M., Ward, S. A., Berry, N. G., Lawrenson, A. S., Hasnain, S. S., Biagini, G. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416611112 · Cited by 101

Authors: Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R.
Affiliations: University of Sheffield (GB)
Wellcome Trust (GB)
Cambridge Crystallographic Data Centre (GB)
Corresponding author: Jones, Gareth
ORCID: Jones, Gareth
Willett, Peter
Glen, Robert C
Leach, Andrew R
Taylor, Robin
Venue: Journal of Molecular Biology
Publisher: Elsevier BV
Published: 1997-04
Volume: 267
Issue: 3
Pages: 727-748
ISSN: 0022-2836 (ISSN-L)
DOI: 10.1006/jmbi.1996.0897
OpenAlex: W2050456292
Cited by: 6,763
References: 87
Citations by year: 2026: 244 · 2025: 332 · 2024: 356 · 2023: 361 · 2022: 383 · 2021: 414 · 2020: 394 · 2019: 351 · 2018: 327 · 2017: 270 · 2016: 248 · 2015: 234 · 2014: 237 · 2013: 248 · 2012: 274
Type: book review
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Molecular Biology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
Keywords: protein-ligand docking, genetic algorithm, flexible docking, protein-ligand complex, ligand conformational flexibility, rational drug design, binding mode prediction
MeSH terms: Algorithms, Binding Sites, Computer Simulation, Humans, Ligands, Models, Genetic, Models, Molecular, NADP, Protein Binding, Protein Conformation, Proteins, Tetrahydrofolate Dehydrogenase, Crystallography, X-Ray

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks